Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a specialty pharmaceutical company, is committed to providing prescription drugs designed to address central nervous system (CNS) disorders. Currently, the company is building a core portfolio of both marketed and development-stage products that attend to substantial, but unmet medical needs. Questcor’s aim is to develop and commercialize their own proprietary products, while staying open to partnering concepts to leverage assets and further build its portfolio. For further information, visit the Company’s web site at www.questcor.com.
- 18 years ago
QualityStocks
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Advances Jameson Land Basin Toward Exploration Drilling
Robert Price, CEO of Greenland Energy Company Energy, Oil & Gas Magazine profiles CEO Robert…
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Terminates Proposed FST Acquisition, Refocuses on Internal Security Technology Development
Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and mobility solutions, announced it has terminated its…
-
QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid…